丝氨酸蛋白酶和乙酰胆碱酯酶高效的不可逆抑制剂。
A potent irreversible inhibitor of serine proteases and acetyl choline esterase.
不可逆抑制剂紧密结合的酶形成基本上是永久的复杂。
Irreversible inhibitors bind tightly to an enzyme to form an essentially permanent complex.
不可逆抑制剂有两大类酶抑制剂，可逆和不可逆的，其酶的亲和力的大小有区别的。
Irreversible inhibitors There are two main classes of enzyme inhibitors, reversible and irreversible, that are differentiated by the magnitude of their affinity for enzyme.
不可逆抑制剂因为它们是永久删除其催化活性的酶，这种紧张复杂，也被称为不可逆抑制剂灭活。
Irreversible inhibitors Because they form such a tight complex with the enzyme that they permanently remove its catalytic activity, irreversible inhibitors are also termed inactivators.
凝血酶及其他丝氨酸蛋白酶的不可逆抑制剂，将活性位点酰基化。比PMSF和DF P毒性小得多。
Irreversible inhibitor of Thrombin and other serine proteases. Inhibits by acylation of the active site of the enzyme. Much less toxic than PMSF and DFP.
一些不可逆抑制剂，甚至成为共价结合的酶的活性部位的氨基酸，因为他们带来的是通过早期的催化化学步骤。
Some irreversible inhibitors even become covalently bound to amino acids in the active site of the enzyme as they are brought through the early chemical steps of catalysis.
抑制剂一般是小分子，他们不可逆转地结合在受体上阻碍其正常功能，而兴奋剂可以是小或大分子。
Antagonists tend to be small molecules that bind irreversibly to the receptor preventing its normal function, while agonists may be small or large molecules (e.g. peptide or protein hormones).
金属蛋白酶可逆的抑制剂，无毒。
作者造成不可逆转的钾离子通道抑制剂，使表征这些谜物。
The authors create irreversible potassium channel inhibitors that enable characterization of these enigmatic complexes.
可逆酶抑制剂的结合和游离与他们在平衡过程中的酶。
Reversible enzyme inhibitors bind and dissociate with their enzyme in a equilibrium process.
经过系统药理学研究表明，该生物碱具有良好抗胆碱酯酶效应，从而可认为该生物碱系一种新结构类型的可逆性胆碱酯酶抑制剂。
The systematic pharmacological study shows that this alkaloid possesses good anticholinesterase effect, and therefore it is a new structure type of reversible acetylcholinesterase inhibitor.
用途：第二代中枢性乙酰胆碱酯酶抑制剂，是一只具有高度选择性、可逆性治疗阿尔茨海默病（老年痴呆）的药物。
Usage: The second generation of central acetylcholinesterase inhibitor, used as a highly selective and reversible treatment of Alzheimer's disease.
本发明涉及用于治疗气道病症的可逆的质子泵抑制剂和气道治疗剂的组合。
The invention relates to the combination of reversible proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
本发明涉及用于治疗气道病症的可逆的质子泵抑制剂和气道治疗剂的组合。
The invention relates to the combination of reversible proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
应用推荐